top of page

The CEO of Arcus Biosciences talks TIGIT, adenosine, and HIF-2α at #ASCO24

Terry Rosen describes data presented at ASCO for TIGIT in upper GI cancers, adenosine in late state colorectal cancer, and non-ASCO data that will be coming up in the second half of the year for HIF-2α in renal.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

bottom of page